Skip to Content

Gentamicin injection

Last Updated: July 10, 2017
Status: Current

Gentamicin injection

Products Affected - Description
    Gentamicin injection, Pfizer
    40 mg/mL, 2 mL vial, 25 count (NDC 00409-1207-03)
    60 mg/50 mL, premixed bag, 24 count (NDC 00409-7879-13) - discontinued
    Reason for the Shortage
      • Pfizer has discontinued all premixed bags.
      • Baxter did not provide a reason for the shortage.
    Available Products
    • Gentamicin injection, Baxter

    60 mg/50 mL, premixed bag, 24 count (NDC 00338-0507-41)
    80 mg/50 mL, premixed bag, 24 count (NDC 00338-0509-41)
    80 mg/100 mL, premixed bag, 24 count (NDC 00338-0503-48)
    100 mg/50 mL, premixed bag, 24 count (NDC 00338-0511-41)
    100 mg/100 mL, premixed bag, 24 count (NDC 00338-0505-48)
    120 mg/100 mL, premixed bag, 24 count (NDC 00338-0507-48)
     
    Gentamicin injection, Fresenius Kabi
    10 mg/mL, 2 mL vial, 25 count (NDC 63323-0173-02)
    40 mg/mL, 2 mL vial, 25 count (NDC 63323-0010-02)
    40 mg/mL, 20 mL vial, 25 count (NDC 63323-0010-20)

    Estimated Resupply Dates

    • Pfizer has gentamicin 40 mg/mL 2 mL vials available in limited supply.

    Updated

    July 10, June 14, May 9, February 24 and 17, January 4, 2017; November 9, August 1, July 15, June 10, May 3, 2016, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

    Hide